The FDA cited insufficient evidence of effectiveness for relacorilant in patients with Cushing syndrome and hypertension, ...
Wedbush Securities analyst Dan Ives, known for his colorful attire and ultra-positive coverage of tech stocks, has ranked his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback